Marshall Wace, LLP Bio Xcel Therapeutics, Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $70,230 - $334,229	28,205 New	28,205 $71,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $802,243 - $1.91 Million	88,842 New	88,842 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $251,258 - $438,203	-12,488 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $297,713 - $399,990	12,488 New	12,488 $379,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.